Literature DB >> 22395291

Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery.

Dennis Miller1, Alfredo L Milani, Suzette E Sutherland, Bonnie Navin, Rebecca G Rogers.   

Abstract

INTRODUCTION AND HYPOTHESIS: Complex issues surround informed surgical consent for pelvic reconstructive surgery.
METHODS: Vaginally placed mesh/grafts are used with the intent to increase durability of the repair but potentially introduce unique complications, offering new challenges in informed surgical consent counseling.
RESULTS: Informed consent is a process that takes place throughout the entire consultation with the patient. A written document often accompanies that process. This paper outlines necessary components of informed surgical consent and the theory behind each component.
CONCLUSIONS: We explore elements that should be included in the consent process with regard to expected benefits, alternatives, and material risks that are specific to the use of a mesh/graft-augmented vaginal repair of prolapse. Included is an appendix that may serve as a template for the creation of a surgeon's own written informed consent document.

Entities:  

Mesh:

Year:  2012        PMID: 22395291     DOI: 10.1007/s00192-012-1680-8

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  31 in total

Review 1.  Surgical management of pelvic organ prolapse in women: a short version Cochrane review.

Authors:  C Maher; K Baessler; C M A Glazener; E J Adams; S Hagen
Journal:  Neurourol Urodyn       Date:  2008       Impact factor: 2.696

2.  Complications of vaginal mesh: our experience.

Authors:  Bernard Jacquetin; Michel Cosson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-10

3.  A randomized controlled trial of pelvic floor muscle training for stages I and II pelvic organ prolapse.

Authors:  Suzanne Hagen; Diane Stark; Cathryn Glazener; Lesley Sinclair; Ian Ramsay
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-20

4.  Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure.

Authors:  Mariëlla I Withagen; Mark E Vierhout; Jan C Hendriks; Kirsten B Kluivers; Alfredo L Milani
Journal:  Obstet Gynecol       Date:  2011-09       Impact factor: 7.661

Review 5.  Informed consent for medical treatment and research: a review.

Authors:  Marcela G del Carmen; Steven Joffe
Journal:  Oncologist       Date:  2005-09

6.  Enhancement of surgical informed consent by addition of repeat back: a multicenter, randomized controlled clinical trial.

Authors:  Aaron S Fink; Allan V Prochazka; William G Henderson; Debra Bartenfeld; Carsie Nyirenda; Alexandra Webb; David H Berger; Kamal Itani; Thomas Whitehill; James Edwards; Mark Wilson; Cynthia Karsonovich; Patricia Parmelee
Journal:  Ann Surg       Date:  2010-07       Impact factor: 12.969

7.  Is pelvic organ prolapse a cause of pelvic or low back pain?

Authors:  Michael Heit; Patrick Culligan; Chris Rosenquist; Susan Shott
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

8.  Management of vaginal erosion of polypropylene mesh slings.

Authors:  Kathleen C Kobashi; Fred E Govier
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

9.  Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients.

Authors:  Fréderic Caquant; Pierre Collinet; Philippe Debodinance; Juan Berrocal; Olivier Garbin; Claude Rosenthal; Henri Clave; Richard Villet; Bernard Jacquetin; Michel Cosson
Journal:  J Obstet Gynaecol Res       Date:  2008-08       Impact factor: 1.730

10.  The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population.

Authors:  Marijke C Ph Slieker-ten Hove; Annelies L Pool-Goudzwaard; Marinus J C Eijkemans; Regine P M Steegers-Theunissen; Curt W Burger; Mark E Vierhout
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15
View more
  4 in total

1.  Implications of the FDA statement on transvaginal placement of mesh: the aftermath.

Authors:  Michelle E Koski; Eric S Rovner
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

Review 2.  Native tissue repair for central compartment prolapse: a narrative review.

Authors:  Dorit Paz-Levy; David Yohay; Joerg Neymeyer; Ranit Hizkiyahu; Adi Y Weintraub
Journal:  Int Urogynecol J       Date:  2016-05-21       Impact factor: 2.894

3.  Changes in prolapse surgery trends relative to FDA notifications regarding vaginal mesh.

Authors:  Laura C Skoczylas; Lindsay C Turner; Li Wang; Daniel G Winger; Jonathan P Shepherd
Journal:  Int Urogynecol J       Date:  2013-10-01       Impact factor: 2.894

Review 4.  Prevention and management of pelvic organ prolapse.

Authors:  Ilias Giarenis; Dudley Robinson
Journal:  F1000Prime Rep       Date:  2014-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.